The Global Fund to Fight AIDS, Tuberculosis, and Malaria has announced six grants totaling $380 million to strengthen Kenya's response to HIV, tuberculosis, and malaria.
The grants, which will be managed by the National Treasury of Kenya, AMREF Health Africa, and the Kenya Red Cross Society, will support efforts to reach 1.3 million people with antiretroviral therapy by 2021 and significantly expand efforts to uncover unreported cases of TB, among other objectives. The funds include $24.8 million to be invested in programs and activities that focus on issues such as human rights, adolescent girls and young women, and other populations most affected by HIV and TB. The government of Kenya has committed an additional $130 million to combat the three diseases.
Between 1996 and 2016, HIV prevalence in Kenya was reduced from 10.5 percent to 5.4 percent. In addition, the East African country has reduced the number of new infections among children by 44 percent since 2009, while malaria prevalence fell from 11 percent in 2010 to 8 percent in 2015.
"Kenya is an excellent example of partnership at work," said Linden Morrison, head of the Global Fund's High Impact Africa II Department. "It was inspiring to see how the country designed the grants by conducting a successful country dialogue, ensuring that key partners were engaged, and that people most affected by the diseases were put front and center of the investments."
(Photo credit: AMREF Health Africa)